Remdesivir shortens COVID-19 recovery time, but limits exist: experts
IndustryJun 8, 2020
Remdesivir shortens recovery time for novel coronavirus patients, but the experimental drug conventionally used for treating Ebola has limited efficacy in severe cases, health experts said Monday. Last week, the Ministry of Food and Drug Safety, South Korea's drug safety watchdog, approved the use of Remdesivir as a treatment drug for COVID-19, allowing special imports by using its special measures procedure. Following the approval, controversies arose on whether Remdesivir, medication develo